Australia markets closed

Yuyu Pharma, Inc. (000227.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
11,420.00+70.00 (+0.62%)
At close: 02:30PM KST
Currency in KRW

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-10.56%
S&P500 52-week change 323.20%
52-week high 321,400.00
52-week low 39,150.00
50-day moving average 311,275.80
200-day moving average 312,128.55

Share statistics

Avg vol (3-month) 31.54k
Avg vol (10-day) 32.7k
Shares outstanding 55.86M
Implied shares outstanding 6N/A
Float 810.54M
% held by insiders 144.47%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 40.80
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 428 Dec 2022
Last split factor 22:1
Last split date 330 Mar 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -1.54%
Operating margin (ttm)13.97%

Management effectiveness

Return on assets (ttm)0.62%
Return on equity (ttm)-0.34%

Income statement

Revenue (ttm)136.32B
Revenue per share (ttm)8,401.41
Quarterly revenue growth (yoy)-2.60%
Gross profit (ttm)N/A
EBITDA 7.65B
Net income avi to common (ttm)-2.06B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)5,286.10%

Balance sheet

Total cash (mrq)29.24B
Total cash per share (mrq)1,806.94
Total debt (mrq)36.63B
Total debt/equity (mrq)29.10%
Current ratio (mrq)2.36
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)4.06B
Levered free cash flow (ttm)-10.27B